A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-024-01406-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Celine M Laffont und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Indivior Inc., North Chesterfield, VA, USA. celine.laffont@indivior.com. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Indivior, Inc..
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Development, Indivior Inc., North Chesterfield, VA, USA. celine.laffont@indivior.com.
- Miami Lakes Medical Research, Miami Lakes, FL, USA.
- Research and Development, Indivior Inc., North Chesterfield, VA, USA.
Förderung
- Indivior, Inc.
Zitieren
APA
Laffont, C. M., Lapeyra, O., Mangal, D., & Dobbins, R. (2024). A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01406-7
Vancouver
Laffont CM, Lapeyra O, Mangal D, Dobbins R. A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01406-7
BibTeX
@article{Laffont2024,
author = {Laffont, Celine M and Lapeyra, Olga and Mangal, Dipti and Dobbins, Robert},
title = {A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-024-01406-7}
}
EUVIMED